Drug intelligence / Profile preview

GSK3074477 FDC

Development stage: Unknown
Lead developer: GSK
Modality: Small Molecules
Administration: Oral

Overview

Information regarding the specific pharmaceutical drug "GSK3074477 FDC" is not publicly available in the provided search results. The suffix "FDC" typically denotes a Fixed Dose Combination, indicating that it is a medication containing two or more active pharmaceutical ingredients in a single dosage form. However, the identity of these active ingredients, its mechanism of action, therapeutic indications, and development status could not be determined from the available data. The search results primarily refer to general concepts of Fixed Dose Combinations or unrelated financial entities with similar acronyms. Therefore, specific details about this particular drug, including its developer and manufacturer, remain unknown.

Brand names: Rosuampin
Other names: rosuvastatin + amlodipineAmlodipine besylate + Rosuvastatin calcium

Targets

CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on GSK3074477 FDC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GSK3074477 FDC.

Explore the full profile